Donald C Kientzler

Title: The Innovations of Donald C Kientzler in Pharmaceutical Development

Introduction

Donald C Kientzler is a noted inventor based in Hightstown, NJ, whose work has significantly advanced the field of pharmaceuticals. He holds a patent that demonstrates his expertise in the production of sterile aripiprazole, a medication used to treat various mental health conditions.

Latest Patents

Mr. Kientzler's sole patent, titled "Process for making sterile aripiprazole of desired mean particle size," outlines a method for producing sterile aripiprazole with an average particle size of less than 100 microns, ideally greater than 25 microns. This innovative process employs an impinging jet crystallization technique that ensures the bulk aripiprazole can be effectively used in sterile freeze-dried formulations. These formulations, when mixed with water and injected intramuscularly, are designed to release the medication over a duration of up to eight weeks, offering a prolonged therapeutic effect for patients.

Career Highlights

Donald C Kientzler is currently associated with Otsuka Pharmaceutical Company, Limited, where he applies his knowledge and skills in pharmaceutical innovation. His work at Otsuka demonstrates a commitment to improving treatment options for patients, showcasing the intersection of science and practical healthcare solutions.

Collaborations

Throughout his career, Mr. Kientzler has worked alongside esteemed colleagues, including Margaret M Gleeson and Soojin Kim. These collaborations emphasize the importance of teamwork and shared expertise in advancing pharmaceutical research and development.

Conclusion

Donald C Kientzler's contributions to the field of pharmaceuticals through his innovative patent highlight his role as a key inventor at Otsuka Pharmaceutical Company, Limited. His work not only pushes the boundaries of science but also aims to enhance the quality of life for patients requiring effective treatment options.